IT
Immuneel Therapeutics
India · Biotech
Cell and gene therapy development and manufacturing, including CAR-T cancer therapies.
Product
Immuneel Therapeutics develops and manufactures cell and gene therapies for cancer care. Its work includes CAR-T treatments, which use a patient’s modified immune cells to target cancer, alongside research into further therapy programmes.
The Bengaluru company combines therapy development with manufacturing and clinical partnerships. It is expanding production capacity and working toward broader access in India and selected international markets.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | >₹1B | Eight Roads Ventures — ParticipantF-Prime Capital — ParticipantKiran Mazumdar-Shaw — ParticipantRainmatter — ParticipantSingularity AMC — Participant |